Practice Management News

Johnson & Johnson Vision announced it is collaborating with Black EyeCare Perspective to grow the percentage of Black people in the eye care industry to 13% to mirror the number of Blacks in the U.S. population.

Among 410 leading medical journals, just 21% had a woman as editor in chief, according to findings published in JAMA Network Open.

The FDA recommended health care providers and individuals avoid using compounded products said to be “sterile, produced and distributed nationwide by Prescription Labs Inc.” that does business as Greenpark Compounding Pharmacy.

An international panel of experts reported that non-inhaled medical cannabis or cannabinoids were associated with modest benefits in patients with chronic pain.

Data from FAIR Health, a nonprofit organization that provides information on health care coverage and insurance, indicate that telehealth use may be dropping after skyrocketing in 2020.

This year’s Women in Medicine Summit will be held virtually on Sept. 24 to Sept. 25. The conference identifies barriers that women in medicine face and offers solutions to gender inequity.

HHS recently announced a plan supporting legislation that would allow it to negotiate Medicare Part B and Part D drug prices directly with pharmaceutical companies and then make those prices available to other purchasers.

It is estimated that the pharmaceutical industry spent more than $24 billion on prescription drug promotion in 2017.

For many physician investors, the present bull run in the U.S. stock market – the longest in its history – has led to long-term concerns about how the markets will fare in the next decade or two.

HHS Secretary Xavier Becerra has announced a plan to lower prescription drug prices by “promoting negotiation, competition and innovation in the health care industry.”